SANDERS MORRIS HARRIS LLC – Alnylam Pharmaceuticals, Inc. Transaction History
SANDERS MORRIS HARRIS LLC portfolio value:
$688,000
portfolio value
SANDERS MORRIS HARRIS LLC quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 169K | $200.16 | 3.5K | |
| Q2 2022 | share | 0.00% | 0 shares | -53K | $145.85 | 3.5K | |
| Q1 2022 | share | 0.00% | 0 shares | -24K | $163.29 | 3.5K | |
| Q4 2021 | share | 0.00% | 0 shares | -118K | $171.03 | 3.5K | |
| Q3 2021 | share | 0.00% | 0 shares | 104K | $188.81 | 3.5K | |
| Q2 2021 | share | 0.00% | 0 shares | 118K | $169.52 | 3.5K | |
| Q1 2021 | share | 0.00% | 0 shares | -106K | $141.19 | 3.5K | |
| Q4 2020 | share | 0.00% | 0 shares | 84K | $129.97 | 3.5K | |
| Q3 2020 | share | Increase | +25.00% | 700 shares | 97K | $145.6 | 3.5K |
| Q2 2020 | share | Increase | 0.00% | 2.8K shares | 417K | $148.11 | 2.8K |